Medtronic OmniaSecureâ"¢ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing Accessibility StatementSkip Navigation Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, received U.S. Food and Drug Administration (FDA) approval for an expanded indication for the OmniaSecur ...